documents: FDA-2022-D-2512-0009

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-2512-0009 FDA FDA-2022-D-2512 Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin; International Council for Harmonisation; Guidance for Industry; Availability Notice Notice of Availability 2024-01-11T05:00:00Z 2024 1 2024-01-11T05:00:00Z   2024-01-11T15:28:46Z 2024-00407 0 0 0900006486392262

Links from other tables